TOPLINE: Patients with early rheumatoid arthritis (RA) who experienced higher levels of sleep disturbances were more likely to have greater difficulties with daily activities because of […]

TOPLINE: Patients with Sjögren disease (SjD) had a 68% higher risk for overall malignancy than the general population, with hematologic malignancies contributing more to this elevated […]

TOPLINE: Patients with moderate to severe active systemic lupus erythematosus (SLE) who continued anifrolumab treatment over 4 years showed sustained improvements in health status and quality […]

TOPLINE: Gender-based differences were identified in the clinical characteristics and time to initiation of the first biologic or targeted synthetic disease-modifying antirheumatic drug (b/ts DMARD) among […]

TOPLINE: Researchers in Japan showed that a unique neutrophil subset, characterized by type II interferon signature genes (T2ISG), along with elevated levels of interferon gamma in […]

TOPLINE: Anti–transcription factor A, mitochondrial (anti-TFAM) antibodies in patients with systemic lupus erythematosus (SLE) were associated with a threefold increased risk for thrombotic events.  METHODOLOGY: Researchers […]

TOPLINE: A substantial proportion of patients with autoimmune diseases experienced a new side effect called local immune effector cell–associated toxicity syndromes (LICATS) after receiving chimeric antigen […]